BULL PHARMA: UNVEILING THE CONTROVERSIES

The term " Disreputable Pharma" has arisen recently, sparking a heated debate surrounding specific pharmaceutical corporations . Allegations of unethical marketing practices, excessive drug costs , and a suspected disregard for patient safety have triggered increasing scrutiny from regulators , p